Esperion Therapeutics Inc
Change company Symbol lookup
Select an option...
ESPR Esperion Therapeutics Inc
PPG PPG Industries Inc
KBNT Kubient Inc
HOSZY Haci Omer Sabanci Holding AS
FREJN Federal Home Loan Mortgage Corp
NXPL NextPlat Corp
$QCF E-MINI NASDAQ COMPOSITE SPOT FIX
CURI CuriosityStream Inc
AXDX Accelerate Diagnostics Inc
MS-I Morgan Stanley
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Esperion Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing and commercializing oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). The Company's bempedoic acid and the bempedoic acid / ezetimibe combination tablets are oral, once-daily, non-statin, LDL-C lowering medicines for patients with atherosclerotic cardiovascular disease (ASCVD), or heterozygous familial hypercholesterolemia (HeFH). The Company's products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. Its NEXLETOL is an ATP Citrate Lyase (ACL), inhibitor that lowers LDL-C by reducing cholesterol biosynthesis and up-regulating the LDL receptors. Its NEXLIZET and NUSTENDI contains bempedoic acid and ezetimibe and lowers elevated LDL-C through complementary mechanisms of action by inhibiting cholesterol synthesis in the liver and absorption in the intestine.

Closing Price
$1.46
Day's Change
-0.03 (-2.01%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.51
Day's Low
1.42
Volume
(Light)
Volume:
1,259,578

10-day average volume:
1,883,351
1,259,578
  • Prev Close
    1.49
  • Today's Open
    1.48
  • Day's Range
    1.42-1.51
  • Avg Vol (10-day)
    1.9M
  • Last (time)
    4:00p ET 05/26/23
  • Last (size)
    60
  • 52-Wk Range
    1.12 - 8.87
    LowHigh
  • (12/07/22 - 04/26/23)
    30.36%
  • 107.8%
  • Market Cap
    138.3M
  • Shares Outstanding
    94.7M
  • -3.40
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.1
  • 82.78
  • (% of float 05/15/23)
    15.49

Latest News

May 25, 2023
4:30 pm ET
Globe Newswire
May 24, 2023
8:00 am ET
Globe Newswire
May 12, 2023
4:30 pm ET
Globe Newswire
May 09, 2023
7:00 am ET
Globe Newswire
May 04, 2023
8:30 am ET
Globe Newswire
May 01, 2023
8:00 am ET
Globe Newswire
April 27, 2023
8:00 am ET
Globe Newswire
April 25, 2023
8:00 am ET
Globe Newswire
April 19, 2023
8:42 am ET
Globe Newswire
April 03, 2023
8:00 am ET
Globe Newswire
March 22, 2023
4:15 pm ET
Globe Newswire
March 20, 2023
8:00 am ET
Globe Newswire
March 16, 2023
11:31 am ET
MarketWatch
8:22 am ET
MarketWatch
March 08, 2023
8:00 am ET
Globe Newswire
March 06, 2023
11:06 am ET
MarketWatch
7:01 am ET
MarketWatch
March 04, 2023
10:30 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.